TP53 and neoplasm: Low prevalence (<10% of allele frequency) mutations were detected in the ASLX1, KIT, PTPN11, and TP53 genes (Supplemental Table  2), along with multiple variants of unknown significance (not included in supplemental data), suggesting that mutated or variant tumor cells comprised only a minor portion of the malignant clone.